Exchange: NSE·Updated 10:30 AM GMT+5:30

SAKAR.NSE News

News
all
press releases
The analyst expects a move above ₹375, with strong support at ₹324 and fundamentals backed by EU oncology approvals.
Stocktwits

Advertisement|Remove ads.